NR 507 Week 6 Discussion; Cirrhosis
Document Preview
Unlock Full 3 Page Document Instantly.
Document Overview
hepatic encephalopathy (HE). Acute changes in mentation, even if mild, are often the earliest indicator of HE and may signal hepatic decompensation (AASLD, 2022). Additionally, infections such as urinary tract infections are well-recognized precipitating factors for HE due to systemic inflammation and increased ammonia production (Fallahzadeh & Rahimi, 2022). Overall, Bayani’s altered mental status in the context of possible infection is consistent with the underlying pathophysiology of cirrhosis, particularly impaired ammonia clearance and cirrhosis-associated immune dysfunction. Identify and justify the diagnostic tests (including labs, imaging, or other diagnostic tests) that would be most appropriate for investigating a diagnosis of your assigned disease process in Bayani. What could the results of these tests look like in your assigned disease process? Initial laboratory testing should include a comprehensive metabolic panel (CMP) and liver function tests (LFTs). In cirrhosis, results may demonstrate elevated bilirubin, mildly elevated or even normal AST/ALT in advanced disease, and elevated alkaline phosphatase depending on etiology. As synthetic function declines, low serum albumin and prolonged prothrombin time (PT)/INR are common due to reduced clotting factor production (Fallahzadeh & Rahimi, 2022), so depending on the stage of cirrhosis that could be present, this could also be a finding. A complete blood count (CBC) may reveal thrombocytopenia from portal hypertension–related splenic sequestration, as well as anemia or leukopenia in advanced disease. It should be noted that ascites is not always present in cases of cirrhosis. Ascites is a complication of decompensated cirrhosis, so it is possible for the body to compensate in the presence of cirrhosis without developing ascites. Because Bayani presents with confusion, a serum ammonia level would be appropriate to assess for hepatic encephalopathy. In cirrhosis, ammonia levels are often elevated due to impaired hepatic detoxification and portosystemic shunting (AASLD, 2022). However, ammonia levels should be interpreted clinically, as they do not always correlate perfectly with severity of symptoms. Given his wife’s concern for a urinary tract infection, a urinalysis and urine culture are essential. Infection is a common precipitating factor for HE in cirrhotic patients due to cirrhosis-associated immune dysfunction (Fallahzadeh & Rahimi, 2022). Findings may include positive leukocyte esterase, nitrites, bacteriuria, and elevated white blood cells.
Full content available after purchase or with an active subscription.
Related Products
Related Products
NR 507 Week 1 Assignment; Immune Response
NR 507 Week 1 Discussion; Allergies and Immunocompromised States
NR 507 Week 1 Discussion; Human Immunodeficiency Virus (HIV)
NR 507 Week 1 Discussion; Immune System Dysfunction & Rash Analysis
NR 507 Week 1 Discussion; Immunity; Hypersensitivity-Immunodeficiency
NR 507 Week 1 Discussion; Introductions (not graded, but required)
NR 507 Week 1 Discussion; Introductions (not graded, but required) & Summary
NR 507 Week 1 Discussion; Pathophysiology and Clinical Aspects of HIV
NR 507 Week 1 Edapt Practice Questions; Hypersensitivity, anemias, immunodeficiency.
NR 507 Week 1 Edapt; Anemias & hemoglobinopathies
NR 507 Week 1 Edapt; Hypersensitivity
NR 507 Week 1 Edapt; Introduction to Anemia
NR 507 Week 1-3 Edapt; Questions and Materials
NR 507 Week 2 Assignment; Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological and Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological Disorders
NR 507 Week 2 Clinical Reasoning Webinar Transcript
NR 507 Week 2 Discussion; Amyotrophic Lateral Sclerosis (ALS)
NR 507 Week 2 Discussion; Choose Your Own Pathophysiology Adventure, Part 1 of 3
NR 507 Week 2 Discussion; Chronic Obstructive Pulmonary Disease
NR 507 Week 2 Edapt Practice Questions; Cardiovascular and Hematology Disorders
NR 507 Week 2 Edapt; Cardio & Hematologic Components; Key Points & Final Review
NR 507 Week 2 Edapt; Cardiovascular and hematology disorders - Practice Questions-Answers
NR 507 Week 2 Edapt; Cardiovascular Disorders
NR 507 Week 2 Edapt; Hematology
NR 507 Week 2 Edapt; Study Guide Anemia
NR 507 Week 3 Assignment; Alterations in Pulmonary Function
NR 507 Week 3 Assignment; Alterations in Pulmonary Function.
NR 507 Week 3 Discussion
NR 507 Week 3 Discussion; Anemia and Its Implications
NR 507 Week 3 Discussion; Heart failure (HF)
NR 507 Week 3 Discussion; Pathophysiology of Anemia and Asthma
NR 507 Week 3 Edapt Practice Questions; Respiratory System
NR 507 Week 3 Edapt; Obstructive and Restrictive Lung Diseases
NR 507 Week 3 Edapt; Respiratory System - Practice Questions-Answers
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders.
NR 507 Week 4 Collaboration Cafe; Cardiovascular Involvement in SLE Pathophysiology
NR 507 Week 4 Collaboration Cafe; Urinary System Pathologies
NR 507 Week 4 Edapt Practice Questions; Urinary, Renal System
NR 507 Week 4 Edapt; Urinary System Pathologies
NR 507 Week 4 Midterm Exam Practice Questions-Answers
NR 507 Week 4 Midterm Exam Solved
NR 507 Week 4 Midterm Exam..
NR 507 Week 4 Midterm Practice Exam Questions (Weeks 1-4)
NR 507 Week 4 Midterm Real Past Exam Questions-Answers
NR 507 Week 4-5 Edapt Questions and Material
NR 507 Week 5 Assignment; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3 - Sickle Cell Disease
NR 507 Week 5 Discussion; COPD and Its Implications
NR 507 Week 5 Edapt; Anxiety Disorders
NR 507 Week 5 Edapt; Depression
NR 507 Week 5 Edapt; GERD; Alterations in the Gastrointestinal System
NR 507 Week 5 Edapt; Inflammatory Bowel Disease
NR 507 Week 5 Edapt; Liver Cirrhosis
NR 507 Week 5 Edapt; Mood Disorders
NR 507 Week 5 Edapt; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Edapt; Peptic Ulcer Disease
NR 507 Week 5 Edapt; Schizophrenia, Ch 19, Pg 618
NR 507 Week 5-6 Edapt Content
NR 507 Week 6 Assignment; Alterations in the Endocrine System
NR 507 Week 6 Case Study; Pathophysiology & Clinical Findings of Type 2 Diabetes
NR 507 Week 6 Discussion
NR 507 Week 7 Assignment; CNS; Sensory and Motor Disorders
NR 507 Week 7 CNS; Sensory and Motor Disorders
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3 - Heart Failure and Neuropathy
NR 507 Week 7 Edapt Content; CNS Sensory and Motor Disorders
NR 507 Week 8 CNS; Brain Disorders & Dermatological Conditions
NR 507 Week 8 Collaboration Cafe
NR 507 Week 8 Collaborative Cafe
NR 507 Week 8 Edapt Content; CNS Brain Disorders
NR 507 Week 8 Final Exam - Questions-Answers
NR 507 Week 8 Final Exam Compilation
NR 507 Week 8 Final Exam Master Study Guide
NR 507 Week 8 Final Exam Master Study Guide - Answered Bullet-by-Bullet.
NR 507 Week 8 Final Exam Review - Made this for the final and really helped me ace it!
NR 507 Week 8 Final Exam Study Guide Review
NR 507 Week 8 Final Exam..
NR 507 Week 8 Group Final Exam Questions
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.